Barclays Initiates Coverage On GoodRx Holdings with Underweight Rating, Announces Price Target of $3
Benzinga Newsdesk 11 months ago
NewsPrice TargetInitiationAnalyst Ratings
Barclays analyst Glen Santangelo initiates coverage on GoodRx Holdings (NASDAQ:GDRX) with a Underweight rating and announces Price Target of $3.
Barclays analyst Glen Santangelo initiates coverage on GoodRx Holdings (NASDAQ:GDRX) with a Underweight rating and announces Price Target of $3.